Developing treatments for drug-resistant cancers
Share this story

Glioblastoma, triple-negative breast cancer and pancreatic cancer are among several types of cancer currently considered treatment resistant. To help develop effective treatments for these and other aggressive forms of cancer, McMaster University launched the Centre for Discovery in Cancer Research (CDCR).

The CDCR brings together Hamilton’s top clinicians and scientists who focus their research on treatment-resistant cancers with high death rates to develop a better biological and genetic understanding of why cancer treatments fail and help identify new forms of therapy that could save lives.

Additionally, the CDCR leverages a “bedside to bench” research mandate, which means doctors taking samples or other observations from cancer patients will collaborate directly with the scientists who model observations in the research labs. Scientists will also leverage artificial intelligence to test samples using patient models and algorithms to help identify new forms of therapy to be tested in clinical trials, identifying possible treatments for the most aggressive and recurring forms of cancer.

For more information, visit McMaster University.

More Stories
Building concrete ideas for the future
Professor influences public policy on global issues such as women’s status in the Middle East
Supporting the health and well-being of older adults in Niagara